Bellarossa & Palermo Development Fund, LLC (CIK: 0002080219) EDGAR, Information, Filings... CompaniesBIO.Com

Bellarossa & Palermo Development Fund, LLC

Mailing address
2976 EAST STATE STREET, SUITE 120 #2126, EAGLE, Idaho, 83616
Phone
208-863-8548
State location
Idaho
State of incorporation
Idaho
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Bellarossa & Palermo Development Fund, LLC (CIK: 0002080219) is an American company incorporated in the state of Idaho. Head office is located at 2976 EAST STATE STREET, SUITE 120 #2126, EAGLE, Idaho, 83616. Work in the industry N/A. Bellarossa & Palermo Development Fund, LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Bellarossa & Palermo Development Fund, LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002080219-25-000002 (33 Act) Size: KB	Aug-06-2025	021-553863 251188625

Recent 20 filings. View all Bellarossa & Palermo Development Fund, LLC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Bellarossa & Palermo Development Fund, LLC overview
Bellarossa & Palermo Development Fund, LLC job
Bellarossa & Palermo Development Fund, LLC stock
Bellarossa & Palermo Development Fund, LLC ownership
Bellarossa & Palermo Development Fund, LLC CEO
Bellarossa & Palermo Development Fund, LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.